Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.
Khan ML, Reeder CB, Kumar SK, Lacy MQ, Reece DE, Dispenzieri A, Gertz MA, Greipp P, Hayman S, Zeldenhurst S, Dingli D, Lust J, Russell S, Laumann KM, Mikhael JR, Leif Bergsagel P, Fonseca R, Vincent Rajkumar S, Keith Stewart A. Khan ML, et al. Among authors: lacy mq. Br J Haematol. 2012 Feb;156(3):326-33. doi: 10.1111/j.1365-2141.2011.08949.x. Epub 2011 Nov 23. Br J Haematol. 2012. PMID: 22107129 Free article.
Retreatment of Multiple Myeloma with Previously Refractory Drugs.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis TV, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: lacy mq. Blood Adv. 2024 Nov 13:bloodadvances.2024014723. doi: 10.1182/bloodadvances.2024014723. Online ahead of print. Blood Adv. 2024. PMID: 39536293
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
Visram A, Rajkumar SV, Kapoor P, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Kumar SK. Visram A, et al. Among authors: lacy mq. Leukemia. 2024 Aug;38(8):1862. doi: 10.1038/s41375-024-02306-7. Leukemia. 2024. PMID: 38956316 No abstract available.
Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design.
Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Kapoor P, Grogan M, Go R, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Gertz MA, Dispenzieri A. Vaxman I, et al. Among authors: lacy mq. Leukemia. 2024 Aug;38(8):1866. doi: 10.1038/s41375-024-02311-w. Leukemia. 2024. PMID: 38886493 Free PMC article. No abstract available.
Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis.
Visram A, Vachon C, Baughn LB, Larson D, Smadbeck J, Dispenzieri A, Kapoor P, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Rajkumar SV, Kumar S. Visram A, et al. Among authors: lacy mq. Leukemia. 2024 Aug;38(8):1865. doi: 10.1038/s41375-024-02309-4. Leukemia. 2024. PMID: 38886492 No abstract available.
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab.
Abdallah N, Murray D, Dispenzieri A, Kapoor P, Gertz MA, Lacy MQ, Hayman SR, Buadi FK, Gonsalves W, Muchtar E, Leung N, Dingli D, Kourelis T, Warsame R, Binder M, Kyle RA, Rajkumar SV, Kumar S. Abdallah N, et al. Among authors: lacy mq. Leukemia. 2024 Aug;38(8):1864. doi: 10.1038/s41375-024-02308-5. Leukemia. 2024. PMID: 38886491 Free PMC article. No abstract available.
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: lacy mq. Blood Cancer J. 2024 Mar 26;14(1):55. doi: 10.1038/s41408-024-01039-1. Blood Cancer J. 2024. PMID: 38531841 Free PMC article.
Academic Promotions in Medicine: An Appraisal of Fairness.
Warsame R, Kim YH, Ouk MY, Mara KC, Lacy MQ, Hayes SN, Shalle Z, Balls-Berry J, Jordan BL, Enders FT, Wolanskyj-Spinner AP, Spinner RJ. Warsame R, et al. Among authors: lacy mq. Mayo Clin Proc. 2024 Mar;99(3):424-434. doi: 10.1016/j.mayocp.2023.05.013. Mayo Clin Proc. 2024. PMID: 38432747
544 results